The XMRV Retrovirus & the Fibromyalgia Connection
Links shared publicly online about this topic.
- 1,668total visits
The XMRV Retrovirus & the Fibromyalgia Connection
View full resource at chronicfatigue.about.com
Tags: Fibromyalgia
Most Recently Shared on October 18, 2009 at 10:40 am By:
The XMRV Retrovirus & the Fibromyalgia Connection http://bit.ly/2r8pLn
AIDSmeds - Top Stories : Report Outlines HIV Cure Research, Important Gaps - by Tim Horn
aidsmeds.com — “Three HIV/AIDS activist groups convened a meeting in March with researchers and representatives of the U.S. Food and Drug Administration (FDA) to describe the current state of cure research and identify barriers to moving such research forward swiftly and smoothly. The proceedings of this meeting, which took place immediately before the 19th Conference on Retroviruses and Opportunistic Infections (CROI) that began on March 5 in Seattle, are now available in a report online.” View full resource at aidsmeds.com
Most Recently Shared on April 25, 2012 at 9:52 pm By:
Top Stories : Report Outlines #HIV #Cure Research, Important Gaps http://t.co/8Oyn9MYq #AIDS @projectinform @tagteam_tweets #atac
AIDSmeds - Top Stories : Electrocauterization Has Fewer Side Effects, Better Efficacy, Than Topical Treatments for Anal Lesions - by Tim Horn
aidsmeds.com — “When it comes to treating precancerous anal lesions, electrocauterization is both more effective and, somewhat surprisingly, better tolerated than repeated topical applications of either Aldara (imiquimod) or Efudex (fluorouracil), according to data presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 26, 2012 at 2:15 am By:
Top Stories : Electrocauterization Is Better Than Topical Treatments for Anal Lesions http://t.co/kqO86ZbZ #HIV #AIDS
AIDSmeds - Top Stories : HCV Testing, Diagnosis Being Overlooked in People With HIV - by Tim Horn
aidsmeds.com — “Although hepatitis C virus (HCV) is a common and serious coinfection among people living with HIV, it often goes undiagnosed, even in a major U.S. city with multiple HIV care providers and a clinic dedicated to caring for people with both infections. This is the finding of a Miami cohort study reported Tuesday, March 6, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 25, 2012 at 10:51 pm By:
#CROI2012 : #HCV Testing, Diagnosis Being Overlooked in People With #HIV http://t.co/Vlc6QxIi #hepatitis #CROI
AIDSmeds - Top Stories : Marker of Active Hep B Infection Declines in Those Coinfected with HIV, Treated with Tenofovir - by Tim Horn
aidsmeds.com — “Prolonged therapy with antiretroviral regimens containing tenofovir is associated with a decline in hepatitis B surface antigen (HBsAg) levels in people coinfected with HIV and hepatitis B virus (HBV), according to a report presented by Dutch researchers at the 19th Conference on Retroviruses and Opportunistic Infections on Tuesday, March 6, in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 21, 2012 at 1:36 pm By:
#CROI2012: Marker of Active #HepB Infection Declines in Those Coinfected w/ #HIV, Treated w/ Tenofovir http://t.co/Yo5GwpNj #CROI #hepatitis
AIDSmeds - Top Stories : Disparities in HIV Treatment Initiation, Viral Load Suppression Vary State-to-State - by Tim Horn
aidsmeds.com — “Some states are lagging behind others in terms of getting people in need of HIV treatment started on medications in a timely fashion, according to new data from a multiple cohort study presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 20, 2012 at 1:03 pm By:
#CROI2012 : Disparities in #HIV Treatment Initiation, Viral Load Suppression Vary State-to-State http://t.co/Ukj9dTh6 #CROI #AIDS
AIDSmeds - Top Stories : ARV Liver Toxicity in HIV/Hep C Coinfected Patients on the Decline - by Tim Horn
aidsmeds.com — “Rates of antiretroviral (ARV)-associated liver toxicity among people living with HIV and hepatitis C virus (HCV) have decreased since 1997, but it is still more common among people infected with both viruses compared with people infected only with HIV. This is the finding of an analysis reported Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 19, 2012 at 3:09 pm By:
#CROI2012 : ARV Liver Toxicity in #HIV / #HepC Coinfected Patients on the Decline http://t.co/zjYQW2FQ #CROI #hepatitis #AIDS
AIDSmeds - Top Stories : Treating HIV During Pregnancy Also Lowers Risk of Transmitting Hep C to Baby - by Tim Horn
aidsmeds.com — “For women living with HIV and hepatitis C virus (HCV) coinfection, using antiretroviral (ARV) therapy during pregnancy may lower the risk of transmitting both viruses to their infants, according to encouraging new data presented Tuesday, March 6, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 16, 2012 at 9:06 pm By:
#CROI2012 : Treating #HIV During Pregnancy Also Lowers Risk of Transmitting #HepC to Baby http://t.co/zzSPwpSq #CROI #hepatitis #AIDS
ARV given to HIV-positive children boosts preventive power of key malaria drug, study shows
news-medical.net — “An antiretroviral (ARV) drug given to HIV-positive children "can boost the preventive power of a key malaria drug," according to a study conducted in Uganda and presented last week at the 19th Conference on Retroviruses and Opportunistic Infections, ScienceNow reports.” View full resource at news-medical.net
Most Recently Shared on March 16, 2012 at 10:12 am By:
HIV/AIDS News: ARV given to HIV-positive children boosts preventive power of key malaria drug, study shows: An a... http://t.co/8Az9np4f
AIDSmeds - Top Stories : GS 7340 Packs Greater HIV Punch, Potentially Better Safety, Versus Viread - by Tim Horn
aidsmeds.com — “A new formulation of the nucleotide reverse transcriptase inhibitor (NRTI) tenofovir, currently dubbed GS 7340, achieves superior efficacy along with far higher concentrations inside the cells targeted by HIV for infection, compared with the current version of tenofovir (found in Viread, Truvada and Atripla). These data, which were presented Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, suggest that the drug may be an excellent candida” View full resource at aidsmeds.com
Most Recently Shared on March 15, 2012 at 10:20 pm By:
AIDSmeds - Top Stories : Inhaled Beclomethasone Bests Fluticasone (Advair) When HIV PIs Being Used - by Tim Horn
aidsmeds.com — “Good news for people living with HIV and asthma, bronchitis and chronic obstructive pulmonary disease (COPD). The inhalable steroid beclomethasone can be used at the same time as HIV protease inhibitors without the increased risk of adrenal suppression, according to a drug interaction study conducted in HIV-negative volunteers reported Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 15, 2012 at 6:34 pm By:
Good news for people living with #HIV and #asthma, #bronchitis and chronic obstructive pulmonary disease http://t.co/GCpQflBU #CROI #AIDS
POZ - Treatment News : Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells - by Tim Horn
poz.com — “Researchers have shown for the first time that it is possible to target and interrupt the mechanism by which HIV remains hidden and unreachable by antiretroviral (ARV) drugs, according to highly anticipated study results presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle. Though no people living with HIV participating in the study saw their virus eradicated as result of the experiment, the findings paint an optimistic picture for scientist” View full resource at poz.com
Most Recently Shared on March 14, 2012 at 6:12 pm By:
Until There's A Cure Health Organization
2 birds 1 stone? Cancer Drug Helps Purge #HIV From Resting Cells http://t.co/lcNvz5Wz @pozmagazine
AIDSmeds - Top Stories : High Blood Pressure Increases Heart Attack Risk in HIV - by Tim Horn
aidsmeds.com — “Elevated blood pressure is associated with a substantially greater risk of a heart attack among people living with HIV, compared with HIV-negative controls, according to a Veterans Health Administration study reported Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 14, 2012 at 1:06 pm By:
Regan Hofmann Health Communicator
RT @aidsmeds: #CROI2012 : High Blood Pressure Increases Heart Attack Risk in #HIV http://t.co/jiy7Szva #AIDS #CROI
AIDSmeds - Top Stories : ‘Quad’ Comparable to Norvir-Reyataz Regimen in Phase III Study - by Tim Horn
aidsmeds.com — “A study of Gilead Sciences? Quad fixed-dose combination tablet containing the experimental integrase inhibitor elvitegravir and boosting agent cobicistat, along with tenofovir and emtricitabine, has met its primary objective, non-inferiority compared with the popular protease inhibitor-based regimen of Norvir (ritonavir)-boosted Reyataz (atazanavir) plus Truvada (tenofovir and emtricitabine), according to data presented Thursday, March 8, at the 19th Conference on Retroviruses and Opportunistic ” View full resource at aidsmeds.com
Most Recently Shared on March 13, 2012 at 9:10 pm By:
#CROI2012 : ‘Quad’ Comparable to Norvir-Reyataz Regimen in Phase III Study http://t.co/ndvybJtU #HIV #AIDS #CROI
AIDSmeds - Top Stories : Black Women Twice as Likely to Die of AIDS in U.S. Compared to White HIV-Positive Women - by Tim Horn
aidsmeds.com — “Some sobering news from the Women?s Interagency HIV Study (WIHS): Black women living with HIV are more likely to progress to AIDS and twice as likely to die of its complications compared with white women living with HIV, according to new results from the cohort presented Tuesday, March 6, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle.” View full resource at aidsmeds.com
Most Recently Shared on March 13, 2012 at 6:50 pm By:
#CROI2012 : Black Women Twice as Likely to Die of #AIDS in U.S. Compared to White HIV-Positive Women http://t.co/GNUilNhF #HIV #CROI
AIDSmeds - Top Stories : Zostavax Shingles Vaccine Generally Safe, Increases Antibody Levels, in People With Stable HIV - by Tim Horn
aidsmeds.com — “Two doses of Zostavax, a vaccine against shingles (herpes zoster), administered six weeks apart is \'generally safe\' for people living with HIV with CD4 counts of 200 or higher and undetectable viral loads, according to study results shared Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI).” View full resource at aidsmeds.com
Most Recently Shared on March 13, 2012 at 1:01 pm By:
#CROI2012 : Zostavax Shingles Vaccine Generally Safe, Increases Antibody Levels, in People With Stable #HIV http://t.co/bxL7E9P6 #CROI #AIDS
Advertisement
